BPS 2110 Lecture Notes - Lecture 6: Receptor Modulator, Sickle-Cell Disease, Phenyl Group

• School: University of Ottawa
• Department: Biopharmaceutical sciences
• Course: BPS 2110
• Professor: Alain Musende

Document Summary

Completely shutting down the enzyme you can say the drug is (cid:1005)(cid:1004)(cid:1004)% effe(cid:272)ti(cid:448)e. i(cid:374) realit(cid:455), (cid:373)a(cid:374)(cid:455) ti(cid:373)es it(cid:859)s (cid:272)o(cid:373)(cid:373)o(cid:374) to see (cid:1009)(cid:1004)% i(cid:374)hi(cid:271)itio(cid:374), this (cid:272)ould (cid:271)e the highest (cid:455)ou (cid:272)a(cid:374) go. There(cid:859)s a dose respo(cid:374)se asso(cid:272)iated (cid:449)ith i(cid:374)hi(cid:271)iti(cid:374)g a(cid:374) e(cid:374)z(cid:455)(cid:373)e. Make great exam questions, asking people to define the difference between efficiency and efficacy. Ideal drug in eyes of pharma (one you need to continuously take throughout your whole life) like crack, you have to take it all the time to maintain health. You need a condition that lasts a lifetime: design a drug that can fill a need. For example, nucleoside reverse transcriptase inhibitors; protease inhibitors interfere at certain points in the life cycle. The (cid:272)urre(cid:374)t (cid:373)ethod of treat(cid:373)e(cid:374)t is a (cid:862)(cid:272)o(cid:272)ktail(cid:863) of drugs; drugs that i(cid:374)hi(cid:271)it e(cid:448)er(cid:455) (cid:272)(cid:455)(cid:272)le of the life (cid:272)(cid:455)(cid:272)le. E(cid:454) people (cid:449)ith hiv (cid:272)a(cid:374) li(cid:448)e i(cid:374)to their (cid:1010)(cid:1004)(cid:859)s. before life e(cid:454)pe(cid:272)ta(cid:374)(cid:272)(cid:455) (cid:449)as a(cid:271)out (cid:1009) (cid:455)ears.